SCHEMBL5286043

SCHEMBL5286043

CC[C@H]1CCCCN1C[C@@H](O)CNS(=O)(=O)c1cccc2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8367106 1.00 SLC6A9 (1.00) SLC6A9
SCHEMBL8365090 0.97 SLC6A9 (1.00) SLC6A9
SCHEMBL5243245 0.89 SLC6A9 (0.80) SLC6A9
SCHEMBL5278409 0.88 SLC6A9 (1.00) SLC6A9
SCHEMBL5242125 0.88 SLC6A9 (1.00) SLC6A9
SCHEMBL8365091 0.87 SLC6A9 (1.00) SLC6A9
SCHEMBL5241059 0.87 SLC6A9 (1.00) SLC6A9
SCHEMBL8367117 0.87 SLC6A9 (0.78) SLC6A9
SCHEMBL5272929 0.87 SLC6A9 (0.78) SLC6A9
SCHEMBL8365516 0.86 SLC6A9 (1.00) SLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1455777-B1 GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS SMITHKLINE BEECHAM PLC (GB) 2007-11-21 EP claimed